Piperidine compounds

Details Piperidine compounds Piperidine compounds

2007-07-03

2007-07-03

Wilson, James O. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S218000, C514S252110, C514S253010, C514S253100, C540S575000, C540S598000, C544S357000, C544S360000, C544S364000, C544S372000

Reexamination Certificate

active

10974329

ABSTRACT:
Disclosed are novel compounds of the formulaAlso disclosed are pharmaceutical compositions comprising the compounds of Formula I.Also disclosed are methods of treating various diseases or conditions, such as, for example, allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) using the compounds of Formula I.Also disclosed are methods of treating various diseases or conditions, such as, for example, allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) using the compounds of Formula I in combination with a H1receptor antagonist.

REFERENCES:
patent: 3401224 (1968-09-01), Barrett et al.
patent: 4725597 (1988-02-01), Devlin et al.
patent: 5463074 (1995-10-01), Shih et al.
patent: 5578616 (1996-11-01), Aslanian et al.
patent: 5633250 (1997-05-01), Shih
patent: 5807872 (1998-09-01), Shih
patent: 5869479 (1999-02-01), Kreutner et al.
patent: 5883096 (1999-03-01), Lowe et al.
patent: 5889006 (1999-03-01), Lowe et al.
patent: 5990147 (1999-11-01), Aslanian
patent: 6034251 (2000-03-01), Aslanian
patent: 6100279 (2000-08-01), Vaccaro et al.
patent: 6448242 (2002-09-01), Ishiwata et al.
patent: 6720328 (2004-04-01), Aslanian et al.
patent: 261611 (1968-05-01), None
patent: 122488 (1984-10-01), None
patent: 0 407 217 (1990-06-01), None
patent: 1101749 (1968-01-01), None
patent: 56/12359 (1981-02-01), None
patent: 68-12359 (1981-02-01), None
patent: WO 95/14007 (1995-05-01), None
patent: WO 98/05292 (1998-02-01), None
patent: WO 98/06394 (1998-02-01), None
patent: WO 99/24405 (1999-05-01), None
patent: WO 99/42446 (1999-08-01), None
patent: WO 00/00488 (2000-01-01), None
patent: WO 00/039092 (2000-07-01), None
patent: WO 02/072093 (2002-09-01), None
Hancock AA, Diehl MS, Fey TA, Bush EN, Faghih R, Miller TR, Krueger KM, Pratt JK, Cowart MD, Dickinson RW, Shapiro R, Knourek-Segel VE, Droz BA, McDowell CA, Krishna G, Brune ME, Esbenshade TA, Jacobson PB, Inflamm Res. Apr. 2005;54 Suppl 1:S27-9.
Arthur A Hancock, Michael E Brune, Expert Opinion on Investigational Drugs, Mar. 2005, vol. 14, No. 3, pp. 223-241.
Hancock AA, Bush EN, Jacobson PB, Faghih R, Esbenshade TA., Histamine H(3) antagonists in models of obesity.Inflamm Res. Mar. 2004;53 Suppl 1:S47-8.
Philips, J.G. et al, Ann. Reports Med. Chem., vol. 31, 1998, 31-40.
Journal of Medicinal Chemistry, 43(12), (2000), pp. 2362-2370.
Arch. Pharm. Pharm. Med. Chem 332 (1999), pp. 389-398.
Arch. Pharm. Pharm. Med. Chem 331 (1998), pp. 395-404.
Stark et al, Drugs of the Future, 21 (5) (1996) 507-520.
Philips et al, Ann. Reports Med. Chem., 31 (1998) 31-40.
Lemoucheux, et al. “Debenzylation of Tertiary Amines Using Phosgene or Triphosgene: An Efficient and Rapid Procedure for the Preparation of Carbamoyl Chlorides and Unsymmetrical Ureus. Application in Carbon-II Chemistry”, J. Org. Chem. (2003) 7289-7297, vol. 68.
Lemoucheux, et al. “Debenzylation of Tertiary Amines using Phosgene or Triphosgene An Efficient and Rapid Procedure for the Preparation of Carbamayl Chlorides and Unsymmetrical Ureas: Application in Carbon-II Chemistry”, J. Org. Chem. (2003) 8742, vol. 68.

Affiliated with

Also associated with

Rating

Piperidine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Piperidine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidine compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3811740